Pasar al contenido principal

APROXIMACIONES DE LA QUIMICA COMPUTACIONAL A MECANISMOS DE LA INMUNIDAD INNATA Y DE RESISTENCIA BACTERIANA.

PID2020-113588RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Integrated NMR-crystallography-computational approach for molecular recognition studies of human Gαi3 protein by a small molecule inhibitor

  • Ferreras-Gutiérrez, Mariola
  • Mínguez-Toral, Marina
  • Ibáñez de Opakua, Alain
  • Martín-Santamaría, Sonsoles
  • García-Marcos, Mikel
  • Medrano, Francisco Javier
  • Blanco García, Francisco J
[Abstract] The small molecule IGGi-11 targets Gαi subunits of heterotrimeric guanine nucleotide-binding proteins. Gα subunits are activated by G-protein-coupled receptors in response to extracellular stimuli by accelerating the exchange of GDP for GTP, but they are also activated by intracellular proteins like GIV, of which elevated levels correlate with increased cell migration and cancer metastasis. IGGi-11 disrupts the interaction of Gαi proteins with GIV and inhibits pro-invasive traits of metastatic breast cancer cells without interfering with GPCR signaling. IGGi-11 is a competitive inhibitor but binds Gαi3 with a 10-fold lower affinity than GIV. To guide the design of higher affinity inhibitors, we aimed at obtaining high-resolution structural data on the complex. To facilitate its crystallization, we have removed the most flexible residues at the chain ends of Gαi3, identified by NMR. While Gαi3 crystals grown with excess IGGi-11 did not show the bound compound, computational docking and molecular dynamics simulations identified the interactions driving the molecular recognition. This approach revealed heterogeneous binding due to the symmetry of IGGi-11 chemical structure and to the elongated shape and flexibility of the binding site. Our results suggest that chemical modifications breaking IGGi-11 symmetry might yield inhibitors with higher affinity and potential as antimetastatic drugs., This work was supported by grants PID2020-113225GB-I00 and PID2023-147699OB-I00 to FJB, grant PID2020-113588RB-I00 and PID2023-152271NB-I00 to SMS, and by the Formación de Personal Investigador contracts PRE2018-085788 to MFG and PRE2021-097247 to MMT, all funded by the Spanish Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033. It was also suppported by grant R01GM147931 from the National Institutes of Health to MGM.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Full-atom model of the agonist LPS-bound toll-like receptor 4 dimer in a membrane environment

  • Martín-Santamaría, Sonsoles
  • Matamoros-Recio, Alejandra
  • Franco-Gonzalez, Juan Felipe
  • Pérez-Regidor, Lucía
  • Billod, Jean-Marc
  • Guzmán-Caldentey, Joan
21 p.-14 fig. In Memoriam Prof. Kilian Muñiz (R.I.P.). Excellent person, great heart., The innate immunity TLR4/MD-2 system is a membrane receptor of paramount importance as therapeutic target. Its assembly, upon binding of Gram-negative bacteria lipopolysaccharide (LPS), and also dependent on the membrane composition, finally triggers the immune response cascade. We here combine ab-initio calculations, molecular docking, all-atom molecular dynamics simulations, and thermodynamics calculations to provide the most realistic and complete 3D models of the active full TLR4 complex embedded into a realistic membrane to date. Our studies reveal functional and structural insights into the transmembrane domain behavior in different membrane environments, the ectodomain bouncing movement, and the dimerization patterns of the intracellular TIR domain. Our work provides TLR4 models as reasonable 3D structures for the (TLR4/MD-2/LPS) 2 architecture accounting for the active (agonist) state of the TLR4, and pointing to a signal transduction mechanism across cell membrane. These observations unveil relevant molecular aspects involved in the TLR4 innate immune pathways and will promote the discovery of new TLR4 modulators., This work was financially supported by the Spanish Ministry for Science and Innovation (grants CTQ2014-57141-R, CTQ2017-88353-R, and PID2020-113588RB-I00; grants BES-2012-053653 for L.P.R., BES-2015-071588 for J.G.C. and PRE2018-086249 for A.M.R.), and the European Commission Marie Sklodowska-Curie actions (H2020-MSCA-ITN 642157 “TOLLerant”)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lipid‑A‑dependent and cholesterol‑dependent dynamics properties of liposomes from gram‑negative bacteria in ESKAPE

  • Franco-Gonzalez, Juan Felipe
  • Matamoros-Recio, Alejandra
  • Torres-Mozas, Ángel
  • Rodrigo-Lacave, Blanca
  • Martín-Santamaría, Sonsoles
15 p.-9 fig., AntiMicrobial Resistance (AMR) is a worldwide health emergency. ESKAPE pathogens include the most relevant AMR bacterial families. In particular, Gram-negative bacteria stand out due to their cell envelope complexity which exhibits strong resistance to antimicrobials. A key element for AMR is the chemical structure of lipid A, modulating the physico-chemical properties of the membrane and permeability to antibiotics. Liposomes are used as models of bacterial membrane infective vesicles. In this work, coarse-grained molecular dynamics simulations were used to model liposomes from ESKAPE Gram-negative bacteria (Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa). We captured the role of lipid A, cardiolipin and cholesterol on liposome morphology and physico-chemical properties. Additionally, the reported antimicrobial peptides Cecropin B1, JB95, and PTCDA1-kf, were used to unveil their implications on membrane disruption. This study opens a promising starting point to understand molecular keys of bacterial membranes and to promote the discovery of new antimicrobials to overcome AMR., This work was financially supported by the Spanish Ministry for Science and Innovation (grants CTQ2017-88353-R, and PID2020-113588RB-I00; grant PRE2018-086249 for A.M.R.) and RES-BSC QSB-2020-2-0017., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

New glucosamine-based TLR4 agonists: design, synthesis, mechanism of action, and in vivo activity as vaccine adjuvants

  • Romerio, Alessio
  • Gotri, Nicole
  • Franco, Ana Rita
  • Artusa, Valentina
  • Shaik, Mohammed Monsoor
  • Pasco, Samuel T.
  • Atxabal, Unai
  • Matamoros-Recio, Alejandra
  • Mínguez-Toral, Marina
  • Zalamea, Juan Diego
  • Franconetti, Antonio
  • Abrescia, Nicola G. A.
  • Jiménez-Barbero, Jesús
  • Anguita, Juan
  • Martín-Santamaría, Sonsoles
  • Peri, Francesco
20 p.-15 fig.-1 graph. abst., We disclose here a panel of small-molecule TLR4 agonists (the FP20 series) whose structure is derived from previously developed TLR4 ligands (FP18 series). The new molecules have increased chemical stability and a shorter, more efficient, and scalable synthesis. The FP20 series showed selective activity as TLR4 agonists with a potency similar to FP18. Interestingly, despite the chemical similarity with the FP18 series, FP20 showed a different mechanism of action and immunofluorescence microscopy showed no NF-κB nor p-IRF-3 nuclear translocation but rather MAPK and NLRP3-dependent inflammasome activation. The computational studies related a 3D shape of FP20 series with agonist binding properties inside the MD-2 pocket. FP20 displayed a CMC value lower than 5 μM in water, and small unilamellar vesicle (SUV) formation was observed in the biological activity concentration range. FP20 showed no toxicity in mouse vaccination experiments with OVA antigen and induced IgG production, thus indicating a promising adjuvant activity., The authors acknowledge the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie, project BactiVax (www.bactivax.eu) grant agreement no. 860325; the consortium CINMPIS; the project of excellence CHRONOS, CHRonical multifactorial disorders explored by NOvel integrated Strategies of the Department of Biotechnology and Biosciences; the Agencia Estatal de Investigacion (Spain) for project PID2021-126130OB-I00 (N.G.A.A.), PID2020-113588RB-I00 (S.M.-S.), PRE2018-086249 (A.M.-R), PRE2021-097247 (M.M.-T.); and project FEDER MINECO, the EM-platform at the CIC bioGUNE for support in cryo-EM imaging. J.J.-B. also thanks funding by CIBERES, an initiative of Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Perkin-Elmer Italia is also acknowledged for providing the cell imaging reagents., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Modeling of transmembrane domain and full-length TLRs in membrane models

  • Matamoros-Recio, Alejandra
  • Mínguez-Toral, Marina
  • Martín-Santamaría, Sonsoles
36 p.-5 fig., Toll-like receptors (TLRs), classified as pattern recognition receptors, have a primordial role in the activation of the innate immunity. In particular, TLR4 binds to lipopolysaccharides (LPS), a membrane constituent of Gram-negative bacteria, and, together with Myeloid Differentiation factor 2 (MD-2) protein, forms a heterodimeric complex which leads to the activation of the innate immune system response. Identification of TLRs has sparked great interest in the therapeutic manipulation of the innate immune system. In particular, TLR4 antagonists may be useful for the treatment of septic shock, certain autoimmune diseases, noninfectious inflammatory disorders, and neuropathic pain, and TLR4 agonists are under development as vaccine adjuvants in antitumoral treatments. Therefore, TLR4 has risen as a promising therapeutic target, and its modulation constitutes a highly relevant and active research area. Deep structural understanding of TLR4 signaling may help in the design and discovery of TLR4-modulating molecules with desirable therapeutic properties. Computational studies of the different independent domains composing the TLR4 were undertaken, to understand the differential domain organization of TLR4 in aqueous and membrane environments, including Liquid-disordered (Ld) and Liquid-ordered (Lo) membrane models, to account for the TLR4 recruitment in lipid rafts over activation. We modeled, by means of all-atom Molecular Dynamics (MD) simulations, the structural assembly of plausible full-length TLR4 models embedded into a realistic plasma membrane, accounting for the active (agonist) state of the TLR4, thus providing an analysis at both atomic/molecular and thermodynamic levels of the TLR4 assembly and biological activity. Our results unveil relevant molecular aspects involved in the mechanism of receptor activation, and adaptor recruitment in the innate immune pathways, and will promote the discovery of new TLR4 modulators and probes., This work was financially supported by the Spanish Ministry for Science and Innovation (grants PID2020-113588RB-I00, PRE2018-086249 for A.M.R. and PRE2021-097247 for M.M.T.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Immune evasion through toll-like receptor 4: the role of the core oligosaccharides from α2-proteobacteria atypical lipopolysaccharides

  • Matamoros-Recio, Alejandra
  • Merino, Javier
  • Gallego-Jiménez, Alicia
  • Conde-Álvarez, Raquel
  • Fresno, Manuel
  • Martín-Santamaría, Sonsoles
15 p.-10 fig., Lipopolysaccharides (LPS) are major players in bacterial infection through the recognition by Toll-like receptor 4 (TLR4). The LPS chemical structure, including the oligosaccharide core and the lipid A moiety, can be strongly influenced by adaptation and modulated to assure bacteria protection, evade immune surveillance, or reduce host immune responses. Deep structural understanding of TLRs signaling is essential for the modulation of the innate immune system in sepsis control and inflammation, during bacterial infection. To advance this knowledge, we have employed computational techniques to characterize the TLR4 molecular recognition of atypical LPSs from different opportunistic members of α2-Proteobacteria, including Brucella melitensis, Ochrobactrum anthropi, and Ochrobactrum intermedium, with diverse immunostimulatory activities. We contribute to unraveling the role of uncommon lipid A chemical features such as bearing very long-chain fatty acid chains, whose presence has been rarely reported, on modulating the proper heterodimerization of the TLR4 receptor complex. Moreover, we further evaluated the influence of the different oligosaccharide cores, including sugar composition and net charge, on TLR4 activation. Our studies contribute to elucidating, from the molecular and biological perspectives, the impact of the α2-Proteobacteria LPS cores and the chemical structure of the atypical lipid A for immune system evasion in opportunistic bacteria., This work was financially supported by the Spanish Ministry for Science and Innovation (grants CTQ2017-88353-R, and PID2020-113588RB-I00 to S.M.S.; grant PRE2018-086249 to A.M.R., and SAF2016-75988 to M.F.), Instituto de Salud Carlos III (RD16/0027/0006), European Commission – NextGenerationEU (Regulation EU 2020/2094) through CSIC's Global Health Platform (PTI Salud Global), Comunidad de Madrid (S2017/BMD-3671. INFLAMUNE-CM) and from Laboratorios Esteve to M.F. and institutional grants from “Fundación Ramón Areces” and “Banco de Santander” to CBMSO. Endless support from S.H.J. is sincerely acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Molecular dynamic simulations of aqueous micellar organometallic catalysis: methane functionalization as a case study

  • Matamoros-Recio, Alejandra
  • Alonso-Rueda, Elia
  • Borrego, Elena
  • Caballero, Ana
  • Pérez, Pedro J.
  • Martín-Santamaría, Sonsoles
13 p.-7 schem. In memory of Professor Gregorio Asensio, Molecular Dynamics (MD) simulations constitute a powerful tool that provides a 3D perspective of the dynamical behavior of chemical systems. Herein the first MD study of the dynamics of a catalytic organometallic system, in micellar media, is presented. The challenging methane catalytic functionalization into ethyl propionate through a silver-catalyzed process has been targeted as the case study. The intimate nature of the micelles formed with the surfactants sodium dodecylsulfate (SDS) and potassium perfluorooctane sulfonate (PFOS) has been ascertained, as well as the relative distribution of the main actors in this transformation, namely methane, the diazo reagent and the silver catalyst, the latter in two different forms: the initial compound and a silver-carbene intermediate. Catalyst deactivation occurs with halide containing surfactants dodecyltrimethylammonium chloride (DTAC) and Triton X-100. Computed simulations allow explaining the experimental results, indicating that micelles behave differently regarding the degree of accumulation and the local distribution of the reactants and their effect in the molecular collisions leading to net reaction., We thank to Ministerio de Ciencia e Innovación for Grants PID2020-113797RB-C21, PID2020-113588RB-I00, and PRE2018-086249, also funded by FEDER “Una manera de hacer Europa”. We also thank Junta de Andalucía (P18-1536RT) and Universidad de Huelva (P. O. Feder UHU-202024). Funding for open access is given by Universidad de Huelva/CBUA., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Deciphering the chemical language of the immunomodulatory properties of Veillonella parvula lipopolysaccharide

  • Pither, Molly D.
  • Andretta, Emanuela
  • Rocca, Giuseppe
  • Balzarini, Fabio
  • Matamoros-Recio, Alejandra
  • Colicchio, Roberta
  • Salvatore, Paola
  • Van Kooyk, Yvette
  • Silipo, A.
  • Granucci, Francesca
  • Martín-Santamaría, Sonsoles
  • Chiodo, Fabrizio
  • Di Lorenzo, Flaviana
14 p.-5 fig.-1 schem., Veillonella parvula, prototypical member of the oral and gut microbiota, is at times commensal yet also potentially pathogenic. The definition of the molecular basis tailoring this contrasting behavior is key for broadening our understanding of the microbiota driven pathogenic and/or tolerogenic mechanisms that take place within our body. In this study, we focused on the chemistry of the main constituent of the outer membrane of V. parvula, the lipopolysaccharide (LPS). LPS molecules indeed elicit pro-inflammatory and immunomodulatory responses depending on their chemical structures. Here we report about the structural elucidation of the LPS from two strains of V. parvula and show important and unprecedented differences in both the lipid and carbohydrate moieties, including the identification of a novel galactofuranose and mannitol-containing O-antigen repeating unit for one of the two strains. Furthermore, by harnessing computational studies, in vitro human cell models, as well as lectin binding solid phase assays, we discovered that the two chemically diverse LPS immunologically behave differently and have attempted to identify the molecular determinant(s) governing this phenomenon. Whether a pro-inflammatory potential has been evidenced for the lipid A moiety, by contrast a plausible “immune modulating” action has been proposed for the peculiar O-antigen portion., This study was supported by the European Research Council (ERC) under the Horizon Europe program under grant agreement No 101039841 (DEBUGGING LPS) and by the project "CLariFY" funded by the MUR Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN) Bando 2022 -grant 2022SHW3KY to F.D.L. and F.C. This work was also supported in part by the Italian Ministry of Foreign Affairs and International Cooperation(Italy-Germany Science and Technology cooperation–Call for joint research proposals for the years 2023-2025). It also benefited ofthe projects “GiVIng” funded by Prin PNRR 2022 to F.C.and F.D.L.(grant P202293ZMC),and H2020-MSCA-ITN-2020 grant agreement 956758 (GLYTUNES) to A.S., F.B., Y.v.K., and F.C., and by the Spanish Ministry for Science and Innovation (grantPID2020-113588RB-I00) to S.M.S. and (grant PRE2018-086249) A.M.R., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Plant cell wall-mediated disease resistance: Current understanding and future perspectives

  • Molina, Antonio
  • Jordá, Lucía
  • Torres, Miguel Ángel
  • Martín-Dacal, Marina
  • Berlanga, Diego José
  • Fernández-Calvo, Patricia
  • Gomez-Rubio, Elena
  • Martín-Santamaría, Sonsoles
26 p.-2 fig.-1 tab., Beyond their function as structural barriers, plant cell walls are essential elements for the adaptation of plants to environmental conditions. Cell walls are dynamic structures whose composition and integrity can be altered in response to environmental challenges and developmental cues. These wall changes are perceived by plant sensors/receptors to trigger adaptative responses during development and upon stress perception. Plant cell wall damage caused by pathogen infection, wounding, or other stresses leads to the release of wall molecules, such as carbohydrates (glycans), that function as damage-associated molecular patterns (DAMPs). DAMPs are perceived by the extracellular ectodomains (ECDs) of pattern recognition receptors (PRRs) to activate pattern-triggered immunity (PTI) and disease resistance. Similarly, glycans released from the walls and extracellular layers of microorganisms interacting with plants are recognized as microbe-associated molecular patterns (MAMPs) by specific ECD-PRRs triggering PTI responses. The number of oligosaccharides DAMPs/MAMPs identified that are perceived by plants has increased in recent years. However, the structural mechanisms underlying glycan recognition by plant PRRs remain limited. Currently, this knowledge is mainly focused on receptors of the LysM-PRR family, which are involved in the perception of various molecules, such as chitooligosaccharides from fungi and lipo-chitooligosaccharides (i.e., Nod/MYC factors from bacteria and mycorrhiza, respectively) that trigger differential physiological responses. Nevertheless, additional families of plant PRRs have recently been implicated in oligosaccharide/polysaccharide recognition. These include receptor kinases (RKs) with leucine-rich repeat and Malectin domains in their ECDs (LRR-MAL RKs), Catharanthus roseus RECEPTOR-LIKE KINASE 1-LIKE group (CrRLK1L) with Malectin-like domains in their ECDs, as well as wall-associated kinases, lectin-RKs, and LRR-extensins. The characterization of structural basis of glycans recognition by these new plant receptors will shed light on their similarities with those of mammalians involved in glycan perception. The gained knowledge holds the potential to facilitate the development of sustainable, glycan-based crop protection solutions., This work was supported by grant PID2021-126006OB-I00 to A.M. and L.J., and grant PID2020-113588RB-I00 to S.M.-S. funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe. D.J.B. was supported by PRE2019-091276 and P.F.-C. by postdoctoral fellowships financially supported by the Severo Ochoa Program for Centres of Excellence in R&D (grants SEV-2016-0672 and CEX2020-000999-S) funded by MCIN/AEI/10.13039/501100011033. M.M.-D. was recipient of PhD fellow (PRE2019-08812) funded by MCIN/AEI/10.13039/501100011033. E.G.-R. was supported by Autonomous Region of Madrid fellowship (S2017/BMD-3673) and the European Commission – Next Generation EU (Regulation EU2020/2094) through CSIC’s Global Health Platform PTI Salud Global., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Integrated NMR-crystallography-computational approach for molecular recognition studies of human Gαi3 protein by a small molecule inhibitor

  • Ferreras-Gutiérrez, Mariola
  • Mínguez-Toral, Marina
  • Ibáñez de Opakua, Alain
  • Martín-Santamaría, Sonsoles
  • García-Marcos, Mikel
  • Medrano, Francisco Javier
  • Blanco, Francisco J.
12 p.-6 fig.-1 tab., The small molecule IGGi-11 targets Gαi subunits of heterotrimeric guanine nucleotide-binding proteins. Gα subunits are activated by G-protein-coupled receptors in response to extracellular stimuli by accelerating the exchange of GDP for GTP, but they are also activated by intracellular proteins like GIV, of which elevated levels correlate with increased cell migration and cancer metastasis. IGGi-11 disrupts the interaction of Gαi proteins with GIV and inhibits pro-invasive traits of metastatic breast cancer cells without interfering with GPCR signaling. IGGi-11 is a competitive inhibitor but binds Gαi3 with a 10-fold lower affinity than GIV. To guide the design of higher affinity inhibitors, we aimed at obtaining high-resolution structural data on the complex. To facilitate its crystallization, we have removed the most flexible residues at the chain ends of Gαi3, identified by NMR. While Gαi3 crystals grown with excess IGGi-11 did not show the bound compound, computational docking and molecular dynamics simulations identified the interactions driving the molecular recognition. This approach revealed heterogeneous binding due to the symmetry of IGGi-11 chemical structure and to the elongated shape and flexibility of the binding site. Our results suggest that chemical modifications breaking IGGi-11 symmetry might yield inhibitors with higher affinity and potential as antimetastatic drugs., This work was supported by grants PID2020-113225GB-I00 and PID2023-147699OB-I00 to FJB, grant PID2020-113588RB-I00 and PID2023-152271NB-I00 to SMS, and by the Formación de Personal Investigador contracts PRE2018-085788 to MFG and PRE2021-097247 to MMT, all funded by the Spanish Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033. It was also suppported by grant R01GM147931 from the National Institutes of Health to MGM, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exploring SARS-CoV-2 spike RBD pockets as targets for generic drugs: a combined computational, biophysical, and biological approach

  • García-Marín, Javier
  • Francés-Gómez, Clara
  • Forcada-Nadal, Alicia
  • Adhav, Anmol
  • Marco-Marín, Clara
  • Rubio, Vicente
  • Marina, Alberto
  • Llácer, José Luis
  • Geller, Ron
  • Martín-Santamaría, Sonsoles
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was a pandemic that killed over 6 million people worldwide, with devastating social and economic impacts still being felt today. Despite the recent and successful development of RNA vaccines, there remains a need for antiviral drugs to treat patients at risk for drug resistance, immunological disorders, or reduced treatment efficacy. In this regard, several computational approaches have been carried out to find small molecules targeting the SARS-CoV-2 Spike S protein, and drug repurposing strategies have been applied to find rapid and accessible candidates for clinical use. In this work, we conduct an exhaustive computational study of the receptor binding domain (RBD) of the spike S protein to identify and characterize druggable pockets and to identify generic drugs as blockers of SARS-CoV-2 entry. The combination of computational screening, biophysical studies in both the RBD (Wuhan-Hu-1 and Omicron BA.1 variants) and Spike protein (Wuhan variant), and the in vitro assays in SARS-CoV-2 Wuhan-Hu-1, Delta, and Omicron BA.1 has led to the identification of generic drugs with S protein binding properties and antiviral activity. Based on in vitro antiviral activity and mechanism of action analysis at the atomic/molecular level, fingolimod exhibited the most promising profile for a possible SARS-CoV-2 antiviral treatment., Funding for this project was provided by grants from the European Commission NextGenerationEU fund (EU 2020/2094) through CSIC’s Global Health Platform (PTI Salud Global), Crue-CSIC-Santander Fondo Supera Covid-19 “BlockAce”, and CSIC Grant (CSIC-COV19-082) to S.M.-S., R.G., V.R., A.M., and J.-L.L. J.G.-M. and S.M.-S. gratefully acknowledge BioSolveIT for providing a one-year SeeSAR license during the Scientific Challenge Summer 2020. Grants PID2020-113588RB-I00 and PID2023-152271NB-I00 to S.M.-S. and PID2020-120322RB-C21 to V.R., funded by the Spanish Ministry for Science and Innovation, are also gratefully acknowledged, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exploring Inhibition of Bacterial Conjugation Coupling Protein TrwB: Novel Ligands to Fight Antimicrobial Resistance Spread

  • Gómez-Rubio, Elena
  • Arana, Lide
  • Vicario-Martín, Roberto
  • Arbé-Carton, Kepa
  • Garbisu, Carlos
  • Martín-Cámara, Olmo
  • Alkorta, Itziar
  • Martín-Santamaría, Sonsoles
Bacterial conjugation is the most sophisticated mechanism for horizontal gene transfer. Conjugative plasmids allow the recipient bacterium to acquire new traits from the donor, such as antimicrobial resistance (AMR). Among the proteins involved in the plasmid transfer machinery, the Type IV Coupling Protein (T4CP) links the relaxosome and the Type IV Secretion System (T4SS). However, despite their biological relevance and their potential as a target to control AMR, only a few T4CPs have been exhaustively studied. The archetype of the T4CP family is the coupling protein of the conjugative plasmid R388, TrwB. The inhibition of TrwB ATPase activity or oligomerization with small-molecule modulators is expected to control the transfer of R388, contributing to combat AMR spread. Following a drug repurposing approach, we have combined in silico screening studies, molecular dynamics (MD) simulations, and in vitro bacterial conjugation assays to identify a small collection of compounds that selectively decrease the frequency of conjugation of the plasmid R388 (30-40%). Our results suggest that this inhibition is the result of the specific interaction of these drugs with TrwB. The search for conjugation inhibitors, via the inactivation of proteins such as T4CPs, rises as a strategy to advance in solutions to combat the silent pandemic of AMR., This work was supported by grants PID2020-113588RB-I00, PID2020-116495RB-I00, and PID2023-152271NB-I00 from the Spanish Ministry of Science and Innovation and Grant IT1578-22 from the Department of Education of the Basque Government., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis of Polyhydroxylated Pyrrolidinyl Analogs of Sugar Nucleotides. Experimental and Computational Studies on Their Interactions With GalNAC-T's

  • Merino, Pedro
  • Juste, Veronica
  • Montesa, Alejandro
  • Pereira, Sandra
  • Orta, Sara
  • Pedrón, Manuel
  • Jiménez, Ana I.
  • Martín-Santamaría, Sonsoles
  • Hurtado-Guerrero, Ramón
  • Delso, Ignacio
  • Tejero, Tomás
Direct coupling between polyhydroxylated pyrrolidinyl β-amino phosphonates and uridine monophosphate (UMP) yields polyhydroxylated pyrrolidinyl analogs of sugar nucleotides suitable inhibitors of N-acetyl-galactosyltransferases. β-Amino phosphonates have been synthesized in an enantiomerically pure form through the nucleophilic addition of a phosphonate to polyhydroxylated cyclic nitrones. The reaction has been studied in detail and excellent diastereoselectivities are obtained in agreement with a stereochemical model well supported by density functional theory calculations. Binding of the nucleotide analogs with N-acetylgalactosyltransferases GalNAc-T2, GalNAc-T14, and GalNAc-T16 has been studied both experimentally and computationally through molecular dynamics simulations. Saturation transfer difference nuclear magnetic resonance experiments and measurement of Kd values have been used to validate the binding model at the active site. These studies provide important information of the role of the pyrophosphate and pyrrolidinyl moieties on the observed affinity, We thank Ministerio de Ciencia e Innovacion (MICINN, Spain) (Projects PID2022-137973NB-I00 and PID2019-104090RB-I00 to P.M.; PID2022 136362NB-I00 to R.H.-G. and PID2020-113588RB-I00 and PID2023 152271NB-I00 to S.M.-S.) and Government of Aragón (Spain) (Grupos Consolidados, E34_20R) for financial support. V.J. and S.P. thank also MICINN for FPI predoctoral contracts. A.M., M.P., and S.O. thank Government of Aragon for predoctoral contracts., Peer reviewed, Sin experimentacion animal ni uso de NAMs
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Targeting toll-like receptors in the immunotherapy era: the chemistry behind TLR modulators

  • Mínguez-Toral, Marina
  • Fernández-Vasco, Gema
  • Furjun, Ameerah B.
  • Matamoros-Recio, Alejandra
  • Martín-Cámara, Olmo
  • Martín-Santamaría, Sonsoles
Toll-like receptors (TLRs) comprise a family of transmembrane pattern-recognition receptors that sense pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), thereby orchestrating innate immune responses. Over the past decade, TLRs have emerged as promising therapeutic targets for infectious, inflammatory, autoimmune, and oncological diseases. This review provides a comprehensive overview of TLR agonists and antagonists reported in the last ten years, highlighting an exceptional range of chemical classes, including peptides, nucleic acids, glycolipids, lipopeptides, and small molecules. We discuss the structural determinants underlying receptor selectivity, the design strategies enabling functional modulation, and the progress in preclinical and clinical development. We also address emerging trends, remaining challenges, and opportunities for the rational design of next-generation TLR modulators with improved selectivity and therapeutic potential., Funding from the Spanish Ministry of Science and Innovation (PID2020-113588RB-I00, PID2023-152271NB-I00, PRE2018-086249, PRE2021-097247, PREP2023-002126, and PCI2025-163261 MICIU/AEI/10.13039/501100011033/UE) and European Commission (ERA4Health Partnership NANOTECMEC 2024. Ref. “NextNano4Cancer” GA No. 101095426 of the EU Horizon Europe Research and Innovation Programme) are gratefully acknowledged., Peer reviewed